Internet Searches for Unproven COVID-19 Therapies in the United States
Open Access
- 1 August 2020
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 180 (8), 1116-1118
- https://doi.org/10.1001/jamainternmed.2020.1764
Abstract
There are no highly effective prescription drug therapies supported by any reliable evidence for the ongoing coronavirus disease 2019 (COVID-19) pandemic of severe acute respiratory syndrome coronavirus 2. However, fears among the public can lead to searches for unproven therapies. Therefore, when several high-profile figures, including entrepreneur Elon Musk and President Donald Trump, endorsed the use of chloroquine, a malarial prophylaxis drug, and hydroxychloroquine (with the antibiotic azithromycin), a lupus and rheumatoid arthritis treatment, to treat COVID-19, it drew massive public attention that could shape individual decision-making.This publication has 5 references indexed in Scilit:
- Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should KnowAnnals of Internal Medicine, 2020
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitroCell Discovery, 2020
- Could Behavioral Medicine Lead the Web Data Revolution?JAMA, 2014
- Automatic Time Series Forecasting: TheforecastPackage forRJournal of Statistical Software, 2008
- Cardiotoxicity of antimalarial drugsThe Lancet Infectious Diseases, 2007